| 2024/04/18 21:57:21 | |
|---|---|
| Price | |
| 84.56 EUR | |
| Difference | 0.36% (0.30) |
General attributes
| ISIN | US09061G1013 |
| Symbol | BMRN |
| Exchange | Stuttgart |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,022 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - (0) |
| Ask (Ask size) | - (0) |
| Open | 84.84 EUR |
| High | 85.04 EUR |
| Low | 84.20 EUR |
| Close (prev. day) | 84.26 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 9 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/18 21:57:21 | |
|---|---|
| Price | |
| 84.56 EUR | |
| Difference | 0.36% (0.30) |
General attributes
| ISIN | US09061G1013 |
| Symbol | BMRN |
| Exchange | Stuttgart |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,022 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - (0) |
| Ask (Ask size) | - (0) |
| Open | 84.84 EUR |
| High | 85.04 EUR |
| Low | 84.20 EUR |
| Close (prev. day) | 84.26 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 9 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +3.93% | -7.50% | +28.55% |
| Perf (abs.) | +3.20 | -6.86 | +18.78 |
| Beta | 0.58 | 0.50 | 0.72 |
| Volatility | 29.08 | 26.88 | 31.66 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 85.10 EUR (15) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 80.26 EUR (6) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 83.14 EUR (3) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 82.47 EUR (10) |
| YTD High | date | 90.08 EUR (2024/01/09) |
| YTD Low | date | 76.68 EUR (2024/03/19) |
| 52 Weeks High | date | 90.58 EUR (2023/12/14) |
| 52 Weeks Low | date | 70.76 EUR (2023/11/07) |
All listings for BIOMARIN PHARMACEUTICAL INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2023/11/24 | 17:35 | 81.02 EUR | 0.00 | 2 |
| Vienna Stock Exchange | 2024/04/18 | 17:32 | 85.34 EUR | 0.00 | 2 |
| Tradegate | 2024/04/18 | 22:26 | 84.64 EUR | 0.02 | 3 |
| Stuttgart | 2024/04/18 | 21:57 | 84.56 EUR | 0.00 | 9 |
| Nasdaq | 2024/04/18 | 22:00 | 90.07 USD | 85.43 | 18,118 |
| Munich | 2024/04/18 | 08:04 | 85.42 EUR | 0.00 | 2 |
| London Stock Exchange | 2023/12/05 | 15:30 | 94.23 USD | 0.00 | 1 |
| Hanover | 2024/04/18 | 08:00 | 84.82 EUR | 0.00 | 3 |
| Frankfurt | 2024/04/18 | 08:02 | 84.84 EUR | 0.00 | 2 |
| Euronext Milan MTF Trading After Hours | - | - | - | 0.00 | - |
| Euronext Milan MTF Global Equity Market | 2024/04/18 | 17:44 | 85.40 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/18 | 19:31 | 84.94 EUR | 0.00 | 7 |
| Berlin | 2024/04/18 | 08:08 | 84.88 EUR | 0.00 | 2 |
Company Logo
Contact Details
| BIOMARIN PHARMACEUTICAL INC. |
| - - |
| 371 Bel Marin Keys Blvd., Suite 210 CA 94949 Novato |
| Telefon: (415) 884-6700 |
| Fax: (415) 382-7889 |
| E-mail: webmaster@biomarinpharm.com |
Company Profile
| - |
Members of Management Board
| Richard Meier | Chairman of Board of Directors |
| Athena Countouriotis | Member of Board of Directors |
| Dennis Slamon | Member of Board of Directors |
| Elaine Heron | Member of Board of Directors |
| May Kin Ho | Member of Board of Directors |
| V. Lawlis | Member of Board of Directors |
| Willard Dere | Member of Board of Directors |
| Barbara Bodem | Member of Board of Directors |
| David Pyott | Member of Board of Directors |
| Elizabeth Anderson | Member of Board of Directors |
| Jean-Jacques Bienaimé | Member of Board of Directors |
| Mark Alles | Member of Board of Directors |
| Mark Enyedy | Member of Board of Directors |
| Robert Hombach | Member of Board of Directors |
| Jean-Jacques Bienaimé | Chairman of Managing Board |
| Brinda Balakrishnan | Member of Executive Committee |
| C. Greg Guyer | Member of Executive Committee |
| Amy Wireman | Member of Executive Committee |
| Brian Mueller | Member of Executive Committee |
| G. Eric Davis | Member of Executive Committee |
| Henry J. Fuchs | Member of Executive Committee |
| Jeff Ajer | Member of Executive Committee |
| Philip Lo Scalzo | Member of Executive Committee |